相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers
Li-Ya Chiu et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT
Sung-E Choi et al.
AGING CELL (2013)
Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver
Hiroya Yamada et al.
CLINICA CHIMICA ACTA (2013)
Dual Role of MicroRNAs in NAFLD
Sara Ceccarelli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease
Rui E. Castro et al.
JOURNAL OF HEPATOLOGY (2013)
Underexpression of miR-34a in Hepatocellular Carcinoma and Its Contribution towards Enhancement of Proliferating Inhibitory Effects of Agents Targeting c-MET
Yiwu Dang et al.
PLOS ONE (2013)
Effects of MicroRNAs on Fucosyltransferase 8 (FUT8) Expression in Hepatocarcinoma Cells
Cinzia Bernardi et al.
PLOS ONE (2013)
Peroxisome Proliferator-Activated Receptor Genetic Polymorphisms and Nonalcoholic Fatty Liver Disease: Any Role in Disease Susceptibility?
Paola Dongiovanni et al.
PPAR RESEARCH (2013)
Epigenetic Regulation of miR-34a Expression in Alcoholic Liver Injury
Fanyin Meng et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
MicroRNAs in metabolism and metabolic disorders
Veerle Rottiers et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet
Volodymyr P. Tryndyak et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Current therapeutic strategies in non-alcoholic fatty liver disease
J. K. Dowman et al.
DIABETES OBESITY & METABOLISM (2011)
The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats
Wei-Qing Li et al.
FEBS JOURNAL (2011)
Adipocyte-specific Inactivation of Acyl-CoA Synthetase Fatty Acid Transport Protein 4 (Fatp4) in Mice Causes Adipose Hypertrophy and Alterations in Metabolism of Complex Lipids under High Fat Diet
Lena-Solveig Lenz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
Silvia Cermelli et al.
PLOS ONE (2011)
MicroRNAs and liver disease
Thomas A. Kerr et al.
TRANSLATIONAL RESEARCH (2011)
microRNAs: Fad or future of liver disease
Ashley M. Lakner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Controlling SIRT1 expression by microRNAs in health and metabolic disease
Jiyoung Lee et al.
AGING-US (2010)
A Pathway Involving Farnesoid X Receptor and Small Heterodimer Partner Positively Regulates Hepatic Sirtuin 1 Levels via MicroRNA-34a Inhibition
Jiyoung Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice
Igor P. Pogribny et al.
LABORATORY INVESTIGATION (2010)
The widespread regulation of microRNA biogenesis, function and decay
Jacek Krol et al.
NATURE REVIEWS GENETICS (2010)
Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo
Jesse J. Smith et al.
BMC SYSTEMS BIOLOGY (2009)
Differential expression of microRNAs in mouse liver under aberrant energy metabolic status
Shengjie Li et al.
JOURNAL OF LIPID RESEARCH (2009)
Bezafibrate at Clinically Relevant Doses Decreases Serum/Liver Triglycerides via Down-Regulation of Sterol Regulatory Element-Binding Protein-1c in Mice: A Novel Peroxisome Proliferator-Activated Receptor α-Independent Mechanism
Takero Nakajima et al.
MOLECULAR PHARMACOLOGY (2009)
A three-dimensional view of the molecular machinery of RNA interference
Martin Jinek et al.
NATURE (2009)
Nonalcoholic Steatohepatitis Is Associated with Altered Hepatic MicroRNA Expression
Onpan Cheung et al.
HEPATOLOGY (2008)
SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase
Xiuyun Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Peroxisome proliferator-activated receptor α protects against obesity-induced hepatic inflammation
Rinke Stienstra et al.
ENDOCRINOLOGY (2007)
Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α
Zachary Gerhart-Hines et al.
EMBO JOURNAL (2007)
Sirtuins as potential targets for metabolic syndrome
Leonard Guarente
NATURE (2006)
AMP-activated protein kinase and the metabolic syndrome
LGD Fryer et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
BB Kahn et al.
CELL METABOLISM (2005)
Minireview: The AMP-activated protein kinase cascade: The key sensor of cellular energy status
DG Hardie
ENDOCRINOLOGY (2003)
分享论文
